Deborah Croom‐Carter

EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins

Leah Fitzsimmons, Rachel Cartlidge, Catherine Chang et al. · Cell Death and Differentiation · 2019 · 63 citations · Full text

Life Sciences, Cancer Biology, Oncology +14

Different Patterns of Epstein-Barr Virus Latency in Endemic Burkitt Lymphoma (BL) Lead to Distinct Variants within the BL-Associated Gene Expression Signature

Gemma L. Kelly, Julianna Stylianou, Jane Rasaiyaah et al. · Journal of Virology · 2012 · 59 citations · Full text

Life Sciences, Molecular Biology, Oncology +11

Multiple Epstein‐Barr Virus Strains in Patients with Infectious Mononucleosis: Comparison of Ex Vivo Samples with In Vitro Isolates by Use of Heteroduplex Tracking Assays

Rosemary J. Tierney, Rachel Hood Edwards, Diane Sitki‐Green et al. · The Journal of Infectious Diseases · 2005 · 51 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +10

Coordinated repression of BIM and PUMA by Epstein–Barr virus latent genes maintains the survival of Burkitt lymphoma cells

Leah Fitzsimmons, Andrew John Boyce, Wenbin Wei et al. · Cell Death and Differentiation · 2017 · 30 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis

Olivia Thomas, Tracey A. Haigh, Deborah Croom‐Carter et al. · PLoS Pathogens · 2024 · 23 citations · Full text

Life Sciences, Immunology, Neurology +17